Related Experiment Video
Updated: Apr 27, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Pre-clinical optical imaging and MRI for drug development in Alzheimer's disease
Maarten Rotman1, Thomas J A Snoeks2, Louise van der Weerd1
1Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Abstract:
Optical and magnetic resonance imaging have the potential to be complementary non-invasive imaging modalities. Yet without advances in imaging technologies and contrast agents both have short-comings that cannot be ignored. In this review we demonstrate the pre-clinical use of the two imaging techniques in Alzheimer's disease, including examples from recent applications and discuss what is needed to improve their applicability for drug discovery.:
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction

